Vanda Pharmaceuticals Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|---|
| LLY | Eli Lilly and | Outperform |
16
|
$770.00 | Buy/Sell | $636.99 | 13.96% | 9 | $693.31B |
| JNJ | Johnson & Johnson | Outperform |
9
|
$154.64 | Buy/Sell | $174.55 | 9.93% | 3 | $372.17B |
| MRK | Merck | Outperform |
2
|
$131.19 | Buy/Sell | $130.51 | 9.00% | 11 | $332.28B |
| ABBV | AbbVie | Outperform |
9
|
$166.42 | Buy/Sell | $178.42 | 9.66% | 11 | $293.88B |
| SAN | Sanofi | Outperform |
16
|
89.17€ | Buy/Sell | 102.80€ | 22.80% | 9 | 111.47€B |
| KLAC | KLA Corp | Outperform |
8
|
$747.68 | Buy/Sell | $644.74 | 1.65% | 11 | $100.67B |
| 4502 | Takeda Pharmaceutical Company | Outperform |
5
|
¥4.13k | Buy/Sell | ¥4.74k | 8.96% | 0 | ¥6.48T |
| TEVA | Teva Pharmaceutical Industries | Outperform |
12
|
$16.29 | Buy/Sell | $11.59 | 4.36% | 9 | $18.45B |
| VTRS | Viatris Inc | Hold |
8
|
$10.98 | Buy/Sell | $11.73 | 9.29% | 5 | $13.32B |
| ITCI | Intra-Cellular Therapies | Outperform |
10
|
$65.00 | Buy/Sell | $79.10 | 39.23% | 10 | $6.86B |
| ALKS | Alkermes | Outperform |
10
|
$24.15 | Buy/Sell | $33.27 | 32.51% | 3 | $4.11B |
| INDV | Indivior PLC | Buy |
14
|
£13.37 | Buy/Sell | £28.89 | 131.34% | 4 | £1.95B |